Stay updated on SOUL Study: Semaglutide in Diabetes Clinical Trial
Sign up to get notified when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.

Latest updates to the SOUL Study: Semaglutide in Diabetes Clinical Trial page
- Check5 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.0%

- Check12 days agoChange DetectedDifference0.1%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Record History.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding lapse notice was removed from the page. This is a minor editorial update.SummaryDifference0.2%

- Check55 days agoChange DetectedThe two screenshots show the same Record History page with no visible changes to core study information; only version history entries are listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference6%

Stay in the know with updates to SOUL Study: Semaglutide in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.